MARLBOROUGH, Mass., Nov. 28, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) announces a delay to previously communicated timelines for commercialization of the LOTUS Edge™ Aortic Valve System* in Europe and the U.S. After initiating a voluntary recall for the LOTUS and LOTUS Edge Aortic Valve Systems earlier this year, Boston Scientific implemented manufacturing process and design […]
Coronary/Structural Heart
How Far Away Are Remote Robotic PCIs?
By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) Recent studies have featured the benefits of robotic PCI as a feasible way to treat CAD. But at the annual TCT conference Oct. 30, Ryan D. Madder, MD, presented the idea of “tele-stenting” over long distances. Is it possible for an operator in […]
RSNA Release: Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
CHICAGO, Nov. 28, 2017 /PRNewswire-USNewswire/ — It’s not the amount of fat in your body but where it’s stored that may increase your risk for heart attack, stroke and diabetes, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA). The […]
European doctors learn to access the heart from any approach with Baylis devices and expanded training program
TORONTO, Nov. 21, 2017 /PRNewswire/ – Baylis Medical Company Inc. has launched a hands-on workshop in Europe that will train cardiologists on innovative tools that enable access to the heart from any approach. This includes a growing number of procedures that require physicians to use major veins that feed into the heart from above […]
HeartStitch® “Sutures The Future” at the TCT in Denver, Colorado
FOUNTAIN VALLEY, Calif., Nov. 20, 2017 /PRNewswire/ — TCT 2017 in Denver, Colorado, provided a forum for Interventional Cardiologists from around the world to discover the HeartStitch® Suture-Based Solutions to Structural Heart Procedures. These key procedures of interest include septal repair, mitral and tricuspid valve repair and new access and closure techniques, all areas HeartStitch® has […]
Xeltis Closes $52M for Replacement Heart Valve Programs
EINDHOVEN, The Netherlands and ZURICH, November 15, 2017 /PRNewswire/ — Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announced the completion of an oversubscribed EUR45 million ($52 million) Series C financing. The funding round was led by a global strategic investor with participation […]
Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure
ANAHEIM, Calif., Nov. 14, 2017 /PRNewswire/ — Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart failure, today announced that it has enrolled the first patients in its global multicenter trial (REDUCE LAP-HF II) of the Interatrial Shunt Device (IASD) […]
Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments
FREMONT, Calif., Nov. 13, 2017 /PRNewswire/ — Plaxgen Inc,developing flow cytometry-based blood diagnostics for plaque-associated diseases, such as atherosclerosis and Alzheimer’s, announced that new research exploring the effect of lipid-lowering drugs, including statins, on the morphology of cholesterol particles in human serum samples was published in the peer-reviewed journal, “Journal of […]
Cambridge’s PlaqueTec Names Former Dimension Therapeutics CEO as New Leader
CAMBRIDGE, England, November 13, 2017 /PRNewswire/ — The Board of Directors of PLAQUETEC LTD (‘PlaqueTec’) today announced the appointment of Annalisa Jenkins, MBBS, FRCP, as the company’s Chief Executive Officer. Dr. Jenkins, most recently CEO of U.S.-based Dimension Therapeutics, will lead the 2018 launch of the pioneering biomarker-based PlaqueTec Liquid Biopsy System(TM) […]
SentreHEART Announces Participation at American Heart Association Scientific Sessions 2017
REDWOOD CITY, Calif.–(BUSINESS WIRE)– SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the American Heart Association (AHA) Scientific Sessions 2017 in Anaheim, California November 11-15, 2017. AHA’s Scientific Sessions attracts nearly 18,000 attendees, with a global presence from more than 100 countries. With a commitment to […]


